Follow
Stefan Kavanagh
Stefan Kavanagh
Discovery Safety Specialist, AstraZeneca
Verified email at astrazeneca.com
Title
Cited by
Cited by
Year
Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis
SJ Tantry, SD Markad, V Shinde, J Bhat, G Balakrishnan, AK Gupta, ...
Journal of medicinal chemistry 60 (4), 1379-1399, 2017
1112017
Reducing attrition in drug development: smart loading preclinical safety assessment
RA Roberts, SL Kavanagh, HR Mellor, CE Pollard, S Robinson, SJ Platz
Drug discovery today 19 (3), 341-347, 2014
1032014
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity
M Naik, V Humnabadkar, SJ Tantry, M Panda, A Narayan, S Guptha, ...
Journal of medicinal chemistry 57 (12), 5419-5434, 2014
952014
AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis
WD Hong, F Benayoud, GL Nixon, L Ford, KL Johnston, RH Clare, ...
Proceedings of the National Academy of Sciences 116 (4), 1414-1419, 2019
682019
Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate
S Hameed P, S Solapure, V Patil, PP Henrich, PA Magistrado, S Bharath, ...
Nature Communications 6 (1), 6715, 2015
682015
Discovery of AZD9833, a potent and orally bioavailable selective estrogen receptor degrader and antagonist
JS Scott, TA Moss, A Balazs, B Barlaam, J Breed, RJ Carbajo, ...
Journal of Medicinal Chemistry 63 (23), 14530-14559, 2020
662020
N-Aryl-2-aminobenzimidazoles: Novel, Efficacious, Antimalarial Lead Compounds
S Ramachandran, S Hameed P, A Srivastava, G Shanbhag, S Morayya, ...
Journal of Medicinal Chemistry 57 (15), 6642-6652, 2014
422014
Aminoazabenzimidazoles, a novel class of orally active antimalarial agents
S Hameed P, M Chinnapattu, G Shanbag, P Manjrekar, K Koushik, ...
Journal of Medicinal Chemistry 57 (13), 5702-5713, 2014
332014
Scaffold morphing leading to evolution of 2, 4-diaminoquinolines and aminopyrazolopyrimidines as inhibitors of the ATP synthesis pathway
SJ Tantry, V Shinde, G Balakrishnan, SD Markad, AK Gupta, J Bhat, ...
MedChemComm 7 (5), 1022-1032, 2016
282016
Human stem cell osteoblastogenesis mediated by novel glycogen synthase kinase 3 inhibitors induces bone formation and a unique bone turnover biomarker profile in rats
PS Gilmour, PJ O'Shea, M Fagura, JE Pilling, H Sanganee, H Wada, ...
Toxicology and applied pharmacology 272 (2), 399-407, 2013
222013
Circumventing seizure activity in a series of G protein coupled receptor 119 (GPR119) agonists
JS Scott, SS Bowker, KJ Brocklehurst, HS Brown, DS Clarke, A Easter, ...
Journal of Medicinal Chemistry 57 (21), 8984-8998, 2014
212014
Discovery of clinical candidate AZD0095, a selective inhibitor of monocarboxylate transporter 4 (MCT4) for oncology
FW Goldberg, JG Kettle, GM Lamont, D Buttar, AKT Ting, TM McGuire, ...
Journal of Medicinal Chemistry 66 (1), 384-397, 2022
142022
Development of Pyrazolopyrimidine Anti-Wolbachia Agents for the Treatment of Filariasis
P McGillan, NG Berry, GL Nixon, SC Leung, PJH Webborn, MC Wenlock, ...
ACS Medicinal Chemistry Letters 12 (9), 1421-1426, 2021
82021
Discovery of a Potent and Orally Bioavailable Zwitterionic Series of Selective Estrogen Receptor Degrader-Antagonists
JS Scott, D Stead, B Barlaam, J Breed, RJ Carbajo, E Chiarparin, ...
Journal of Medicinal Chemistry 66 (4), 2918-2945, 2023
72023
Enhanced hepatic respiratory capacity and altered lipid metabolism support metabolic homeostasis during short-term hypoxic stress
KA O’Brien, BD McNally, AP Sowton, A Murgia, J Armitage, LW Thomas, ...
BMC biology 19, 1-20, 2021
32021
Reducing attrition in drug development: Smart loading pre-clinical safety assessment
S Kavanagh, H Mellor, C Pollard, S Robinson, S Platz, R Roberts
Toxicology Letters, S167, 2014
22014
Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b Inhibitors
AM Mfuh, JA Boerth, G Bommakanti, C Chan, AJ Chinn, E Code, PJ Fricke, ...
Journal of Medicinal Chemistry 67 (2), 1500-1512, 2024
12024
Discovery of a Novel Benzodiazepine Series of Cbl-b Inhibitors for the Enhancement of Antitumor Immunity
JA Boerth, AJ Chinn, M Schimpl, G Bommakanti, C Chan, EL Code, ...
ACS Medicinal Chemistry Letters 14 (12), 1848-1856, 2023
12023
Acetylcholinesterase: Is there a recommended level of off target activity that can be tolerated and predicted safe?
LR Ribeiro, M Morton, L Wright, S Kavanagh, M Rolf, D Armstrong, ...
Journal of Pharmacological and Toxicological Methods 70 (3), 327, 2014
12014
Data supporting" Enhanced hepatic respiratory capacity and altered lipid metabolism supports metabolic homeostasis during short-term hypoxic stress"
K O'Brien, B McNally, A Sowton, A Murgia, J Armitage, L Thomas, ...
2021
The system can't perform the operation now. Try again later.
Articles 1–20